676324-78-0

Basic information

• Product Name: Heptanamide, N-methoxy-5-[(4-methoxyphenyl)methoxy]-N,3,6,6-tetramethyl-, (3R,5S)-
• CAS NO: 676324-78-0
• Molecular Formula: C20H33NO4
• Molecular Weight: 351.486
• Mol File: 676324-78-0.mol

Chemical Properties

• CAS DataBase Reference: Heptanamide, N-methoxy-5-[(4-methoxyphenyl)methoxy]-N,3,6,6-tetramethyl-, (3R,5S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Heptanamide, N-methoxy-5-[(4-methoxyphenyl)methoxy]-N,3,6,6-tetramethyl-, (3R,5S)-(676324-78-0)
• EPA Substance Registry System: Heptanamide, N-methoxy-5-[(4-methoxyphenyl)methoxy]-N,3,6,6-tetramethyl-, (3R,5S)-(676324-78-0)

Safety Data

• Hazardous Substances Data: 676324-78-0(Hazardous Substances Data)

Upstream product

• 2746-25-0 p-Methoxybenzyl bromide 
• 676324-82-6 (3R,5S)-5-hydroxy-3,6,6-trimethylheptanoic acid N-methoxy-N-methylamide 
• 67760-86-5 (3S)-2,2-dimethyl-5-hexen-3-ol 
• 582321-91-3 (S)-6-(tert-butyl)-5,6-dihydro-2H-pyran-2-one 
• 582321-69-5 (S)-acrylic acid 1-tert-butyl-but-3-enyl ester 
• 676324-73-5 (3S)-3-(para-methoxybenzyloxy)-4,4-dimethylpentanal 
• 676324-74-6 (4S)-3-[(5S)-5-(4-methoxybenzyloxy)-6,6-dimethylhept-2-enoyl]-4-phenyloxazolidin-2-one 
• 197454-20-9 (S)-5,5-dimethyl-4-hydroxyhexan-2-one 
• 630-19-3 pivalaldehyde 
• 612492-55-4 (S)-5,5-dimethyl-4-(tert-butyldimethylsilyloxy)hexan-2-one 
• 612492-41-8 (S)-tert-butyl (1-tert-butylbut-3-enyloxy)dimethylsilane 
• 89238-99-3 O-(4-methoxybenzyl)-trichloroacetimidate 

Downstream Products

• 676324-80-4 (3R,4S,6S,8S)-8-(4-methoxybenzyloxy)-3,6,9,9-tetramethyldec-1-en-4-ol 
• 676324-81-5 (3R,4S,6S,8S)-8-(4-methoxybenzyloxy)-3,6,9,9-tetramethyl-4-(tert-butyldimethylsilanyloxy)dec-1-ene 
• 1177263-65-8 (3R,4S,6S,8S)-8-(4-methoxybenzyloxy)-3,6,9,9-tetramethyldec-1-en-4-yl 2,2,2-trichloroethyl carbonate 
• 1333536-68-7 pyrrolidine-1,2-dicarboxylic acid (2S)-2-{(1S,3S,5S,6S)-6-[(1S)-3-allyloxycarbonyl-1-[(triphenylmethylthio)methyl]propylcarbamoyl]-1-tert-butyl-5-(2,2,2-trichloroethoxycarbonyloxy)-3-methylhept-1-yl}ester 1-(9H-fluoren-9-ylmethyl)ester 
• 1334149-94-8 apratoxin S₄ 
• 1585181-02-7 (4S,6S,8S)-8-(4-methoxybenzyloxy)-6,9,9-tetramethyldec-1-en-4-ol 
• 1585180-71-7 methyl (3S,5S,7S)-3-hydroxy-7-(4-methoxybenzyloxy)-2,2,5,8,8-pentamethylnonanoate 
• 1585180-73-9 (3S,5S,7S)-3-hydroxy-7-(4-methoxybenzyloxy)-2,2,5,8,8-pentamethylnonanoic acid 
• 1585180-75-1 allyl (3S,5S,7S)-3-hydroxy-7-(4-methoxybenzyloxy)-2,2,5,8,8-pentamethylnonanoate 
• 1585181-32-3 pyrrolidine-1,2-dicarboxylic acid (2S)-2-{(1S,3S,5S)-6-[(1S)-3-allyloxycarbonyl-1-[(triphenylmethylthio)methyl]propylcarbamoyl]-1-tert-butyl-3,6-dimethyl-5-(2,2,2-trichloroethoxycarbonyloxy)-hept-1-yl}ester 1-(9H-fluoren-9-ylmethyl)ester 
• 1585181-34-5 pyrrolidine-1,2-dicarboxylic acid (2S)-2-{(1S,3S,5S,6S)-6-[(1R)-3-allyloxycarbonyl-1-[(triphenylmethylthio)methyl]propylcarbamoyl]-1-tert-butyl-3-methyl-5-(2,2,2-trichloroethoxycarbonyloxy)hept-1-yl}ester 1-(9H-fluoren-9-ylmethyl)ester 
• 1585186-80-6 apratoxin S₁₀ 
• 1585186-81-7 apratoxin S₉ 
• 1585180-89-7 pyrrolidine-1,2-dicarboxylic acid (2S)-2-{(1S,3S,5S)-6-[(1S)-3-allyloxycarbonyl-1-[(triphenylmethylthio)methyl]propylcarbamoyl]-1-tert-butyl-5-hydroxy-3-methylhex-1-yl}ester 1-(9H-fluoren-9-ylmethyl)ester 

Relevant articles and documents

MACROCYCLIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE, AND METHODS OF TREATMENT

The instant invention describes macrocyclic compounds having therapeutic activity, and the mechanism and methods of treating disorders such as autoimmune diseases, inflammation, and cancer, tumors and cell proliferation related disorders.

Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity

Apratoxins are cytotoxic natural products originally isolated from marine cyanobacteria that act by preventing cotranslational translocation early in the secretory pathway to downregulate receptor levels and inhibit growth factor secretion, leading to pot

Synthesis of the polyketide segment of apratoxin A

Apratoxin A 1 is a potent cytotoxic agent extracted from a marine cyanobacterium. We report the results of our synthetic approaches to the polyketide segment 3-OTBS-7-OPMB-2,5,8,8-tetramethylnonanoic acid 4, and the scope and limitations of these approach